𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Outcomes after definitive treatment for cutaneous angiosarcoma of the face and scalp

✍ Scribed by B. Ashleigh Guadagnolo; Gunar K. Zagars; Dejka Araujo; Vinod Ravi; Thomas D. Shellenberger; Erich M. Sturgis

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
206 KB
Volume
33
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Background

The aim of the present analysis was to retrospectively evaluate outcomes in patients with cutaneous angiosarcoma of the face/scalp treated curatively with surgery, radiation therapy (RT), or a combination of surgery and RT.

Methods

In all, 70 patients with nonmetastatic angiosarcoma underwent surgery, RT, or combined‐modality therapy. Of these, 20 patients (29%) were treated with surgery alone, 27 patients (39%) with RT alone, and 23 patients (33%) with combined‐modality therapy; 44 patients received chemotherapy, either neoadjuvantly or adjuvantly or both.

Results

Median follow‐up was 2.1 years. The overall survival (OS) rate was 43% at 5 years, and disease‐specific survival (DSS) was 46% at 5 years. Tumor size > 5 cm and satellitosis were prognostic for inferior OS and DSS. Combined‐modality therapy (vs surgery alone or RT alone) was associated with improved OS, DSS, and local control.

Conclusions

Primary local therapy with combined‐modality therapy was associated with improved local control, OS, and DSS for patients with angiosarcoma of the face/scalp. © 2010 Wiley Periodicals, Inc. Head Neck, 2011

📜 SIMILAR VOLUMES

Paclitaxel in the treatment of patients
Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face
✍ Farid Fata; Eileen O'Reilly; David Ilson; David Pfister; David Leffel; David P. 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 1 views

## BACKGROUND. Angiosarcomas are rare tumors. Based on a complete response observed in a patient with angiosarcoma of the scalp treated with paclitaxel in a Phase II trial, the authors treated a cohort of patients with angiosarcoma of the scalp or face with paclitaxel as single agent. ## METHODS.

Neoadjuvant chemotherapy–specific and ov
Neoadjuvant chemotherapy–specific and overall treatment outcomes in patients with cutaneous angiosarcoma of the face with periorbital involvement
✍ Sheri L. DeMartelaere; Dianna Roberts; Michael A. Burgess; William H. Morrison; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 353 KB

## Abstract ## Background Recent isolated case reports have suggested a potential role for neoadjuvant chemotherapy in patients with angiosarcoma. The goal of this report was to investigate the overall treatment outcomes and the neoadjuvant chemotherapy–specific outcomes in patients with cutaneous

The rapid onset of cutaneous angiosarcom
The rapid onset of cutaneous angiosarcoma after radiotherapy for breast carcinoma
✍ Christopher N. Otis; Richard Peschel; Charles McKhann; Maria J. Merino; Paul Har 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Malignant neoplasms known to develop following external beam radiation include squamous cell carcinoma, osteosarcoma, chondrosarcoma, malignant fibrous histiocytoma, mixed mullerian tumors, malignant schwannoma, myelogenous leukemia and angiosarcoma. Latency periods of many years characterize the on

Impact of race on outcome after definiti
Impact of race on outcome after definitive radiotherapy for squamous cell carcinoma of the head and neck
✍ Majid O. F. Al-Othman; Christopher G. Morris; Henrietta L. Logan; Russell W. Hin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 2 views

## Background: The objective of the current study was to evaluate the impact of race (black vs. white) on the outcome of patients with invasive squamous cell carcinoma of the head and neck. ## Methods: Between 1983 and 1997, 686 patients completed definitive, twice-daily radiotherapy (rt) alone o

Treatment outcome for 424 primary cases
Treatment outcome for 424 primary cases of clinical stage I cutaneous malignant melanoma of the head and neck
✍ William J. Kane; Patricia Yugueros; Ricky P. Clay; John E. Woods 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 2 views

Background. Cutaneous malignant melanoma (CMM) is increasing in frequency. Surgery remains the primary and only curative treatment method. Our aim was to define prognostic factors and outcome predictors for patients with clinical stage I CMM of the head and neck. Methods. Surgical treatment and out